Streetbeat News

Products Services

F

Ford Motor Co's CEO, Jim Farley, praised the company's engineers for their innovative design of the new Transit Custom van's steering wheel, which can flip to serve as a makeshift eating table or a laptop desk. The feature has sparked various reactions online, with some users curious about when it might be available in other Ford vehicles. The Transit Custom van is not available in the United States.

Portfolio Pulse from Anan Ashraf

October 12, 2023 | 11:46 am

MSFT

OpenAI, the parent company of ChatGPT, is planning to introduce significant enhancements for developers to reduce the cost and increase the speed of creating software applications. The updates include introducing memory storage to developer tools and vision capabilities. These innovations could potentially cut expenses by up to 20 times. OpenAI, backed by Microsoft Corp, is transitioning from being a consumer hit to establishing a prominent developer platform. The company aims to generate over $1 billion in revenue over the next 12 months from selling artificial intelligence software and computing capacity.

Portfolio Pulse from Anusuya Lahiri

October 12, 2023 | 11:44 am

BMY

Bristol Myers Squibb (BMY) has announced the presentation of data from over 55 studies across its oncology portfolio at the European Society for Medical Oncology. The studies are sponsored by Bristol Myers Squibb, investigators, and collaborations, and cover more than 10 tumor types.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:40 am

CYT

Cyteir Therapeutics (NASDAQ:CYT) presented ongoing results from a Phase 1 combination study of CYT-0851 with capecitabine in patients with platinum-refractory or -resistant ovarian cancer at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics meeting.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:36 am

NVO

Germany's federal drug regulator, BfArM, has warned pharmacies and drug distributors about counterfeit batches of Novo Nordisk's diabetes medication, Ozempic. The counterfeit injection pens closely resemble the authentic ones in terms of packaging. The regulator has assumed control of the investigation and has called upon distributors and pharmacies to exercise extreme caution. Novo Nordisk also faces significant challenges in ramping up production to meet the overwhelming demand for Ozempic and the weight-loss drug Wegovy.

Portfolio Pulse from Vandana Singh

October 12, 2023 | 11:36 am

OFIX

Orthofix Medical has announced the 510K clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. This development could potentially boost the company's revenues and market share in the medical devices sector.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:30 am

NSPR

InspireMD has announced its support for the Centers for Medicare & Medicaid Services' final National Coverage Determination, which expands coverage of carotid artery stenting and transcarotid artery revascularization to include asymptomatic and standard risk patients.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:29 am

PEPG

The FDA has lifted the full clinical hold and cleared PepGen's Investigational New Drug application to initiate the FREEDOM-DM1 Phase 1 study of PGN-EDODM1 for Myotonic Dystrophy Type 1.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:27 am

BNTX

Medilink Therapeutics has entered into a strategic research collaboration and worldwide license agreement with BioNTech for the development of a next-generation antibody-drug conjugate candidate, against human epidermal growth factor receptor 3.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 11:25 am

IGT

International Game Technology PLC (IGT) has signed a 10-year contract extension with Pan Malaysian Pools SDN BHD. Under the extension, IGT will upgrade PMP's existing system technology to IGT's central lottery system, Aurora. The financial terms were not disclosed.

Portfolio Pulse from Shivani Kumaresan

October 12, 2023 | 11:24 am